56 related articles for article (PubMed ID: 3494718)
1. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
2. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.
Duquesnoy RJ; Awadalla Y; Lomago J; Jelinek L; Howe J; Zern D; Hunter B; Martell J; Girnita A; Zeevi A
Transpl Immunol; 2008 Feb; 18(4):352-60. PubMed ID: 18158123
[TBL] [Abstract][Full Text] [Related]
3. Peptide binding predictions for HLA DR, DP and DQ molecules.
Wang P; Sidney J; Kim Y; Sette A; Lund O; Nielsen M; Peters B
BMC Bioinformatics; 2010 Nov; 11():568. PubMed ID: 21092157
[TBL] [Abstract][Full Text] [Related]
4. Antibody verification of HLA class I and class II eplets by human monoclonal HLA antibodies.
Kramer CSM; Bezstarosti S; Franke-van Dijk MEI; Vergunst M; Roelen DL; Uyar-Mercankaya M; Voogt-Bakker KH; Heidt S
HLA; 2024 Jan; 103(1):e15345. PubMed ID: 38239050
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR, -DP, -DQ expression status of parathyroid tissue as a potential parathyroid donor selection criteria and review of literature.
Goncu B; Yucesan E; Ersoy YE; Aysan ME; Ozten Kandas N
Hum Immunol; 2022 Feb; 83(2):113-118. PubMed ID: 34955228
[TBL] [Abstract][Full Text] [Related]
6. Specificity of HLA monoclonal antibodies and their use to determine HLA expression on lymphocytes and peripheral blood stem cells.
Peton B; Taniguchi M; Mangiola M; Al Malki MM; Gendzekhadze K
HLA; 2024 Jan; 103(1):e15192. PubMed ID: 37596840
[TBL] [Abstract][Full Text] [Related]
7. Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas.
Tawara T; Hasegawa K; Sugiura Y; Tahara T; Ishida I; Kataoka S
Cancer Sci; 2007 Jun; 98(6):921-8. PubMed ID: 17428256
[TBL] [Abstract][Full Text] [Related]
8. Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learning.
Nilsson JB; Kaabinejadian S; Yari H; Kester MGD; van Balen P; Hildebrand WH; Nielsen M
Sci Adv; 2023 Nov; 9(47):eadj6367. PubMed ID: 38000035
[TBL] [Abstract][Full Text] [Related]
9. Generation and expression analysis of BAC humanized mice carrying HLA-DP401 haplotype.
Li F; Zhu MM; Niu BW; Liu LL; Peng XH; Yang H; Qin BY; Wang M; Ren X; Zhou X
Animal Model Exp Med; 2021 Jun; 4(2):116-128. PubMed ID: 34179719
[TBL] [Abstract][Full Text] [Related]
10. Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.
Hartman K; Steiner G; Siegel M; Looney CM; Hickling TP; Bray-French K; Springer S; Marban-Doran C; Ducret A
Biology (Basel); 2023 Sep; 12(9):. PubMed ID: 37759665
[TBL] [Abstract][Full Text] [Related]
11. Target Therapy in Hematological Malignances: New Monoclonal Antibodies.
Podhorecka M; Markowicz J; Szymczyk A; Pawlowski J
Int Sch Res Notices; 2014; 2014():701493. PubMed ID: 27433507
[TBL] [Abstract][Full Text] [Related]
12. Dissecting Genetic Control of HLA-DPB1 Expression and Its Relation to Structural Mismatch Models in Hematopoietic Stem Cell Transplantation.
Meurer T; Arrieta-Bolaños E; Metzing M; Langer MM; van Balen P; Falkenburg JHF; Beelen DW; Horn PA; Fleischhauer K; Crivello P
Front Immunol; 2018; 9():2236. PubMed ID: 30344521
[TBL] [Abstract][Full Text] [Related]
13. Membranal and Blood-Soluble HLA Class II Peptidome Analyses Using Data-Dependent and Independent Acquisition.
Ritz D; Sani E; Debiec H; Ronco P; Neri D; Fugmann T
Proteomics; 2018 Jun; 18(12):e1700246. PubMed ID: 29314611
[TBL] [Abstract][Full Text] [Related]
14. A dual-targeting triplebody mediates preferential redirected lysis of antigen double-positive over single-positive leukemic cells.
Schubert I; Saul D; Nowecki S; Mackensen A; Fey GH; Oduncu FS
MAbs; 2014; 6(1):286-96. PubMed ID: 24135631
[TBL] [Abstract][Full Text] [Related]
15. Pulse-chase analysis for studies of MHC class II biosynthesis, maturation, and peptide loading.
Hou T; Rinderknecht CH; Hadjinicolaou AV; Busch R; Mellins E
Methods Mol Biol; 2013; 960():411-432. PubMed ID: 23329504
[TBL] [Abstract][Full Text] [Related]
16. A cancer vaccine induces expansion of NY-ESO-1-specific regulatory T cells in patients with advanced melanoma.
Ebert LM; MacRaild SE; Zanker D; Davis ID; Cebon J; Chen W
PLoS One; 2012; 7(10):e48424. PubMed ID: 23110239
[TBL] [Abstract][Full Text] [Related]
17. A novel variant marking HLA-DP expression levels predicts recovery from hepatitis B virus infection.
Thomas R; Thio CL; Apps R; Qi Y; Gao X; Marti D; Stein JL; Soderberg KA; Moody MA; Goedert JJ; Kirk GD; Hoots WK; Wolinsky S; Carrington M
J Virol; 2012 Jun; 86(12):6979-85. PubMed ID: 22496224
[TBL] [Abstract][Full Text] [Related]
18. DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.
Rinderknecht CH; Roh S; Pashine A; Belmares MP; Patil NS; Lu N; Truong P; Hou T; Macaubas C; Yoon T; Wang N; Busch R; Mellins ED
Immunology; 2010 Sep; 131(1):18-32. PubMed ID: 20408893
[TBL] [Abstract][Full Text] [Related]
19. Class II MHC antigen presentation defect in neonatal monocytes is not correlated with decreased MHC-II expression.
Canaday DH; Chakravarti S; Srivastava T; Tisch DJ; Cheruvu VK; Smialek J; Harding CV; Ramachandra L
Cell Immunol; 2006 Oct; 243(2):96-106. PubMed ID: 17324388
[TBL] [Abstract][Full Text] [Related]
20. Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.
Chen Q; Jackson H; Parente P; Luke T; Rizkalla M; Tai TY; Zhu HC; Mifsud NA; Dimopoulos N; Masterman KA; Hopkins W; Goldie H; Maraskovsky E; Green S; Miloradovic L; McCluskey J; Old LJ; Davis ID; Cebon J; Chen W
Proc Natl Acad Sci U S A; 2004 Jun; 101(25):9363-8. PubMed ID: 15197261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
